The downside to downsizing

May 24, 2004

It used to be that the pharmaceutical industry was virtually recession-proof. When times were bad, the unemployed had more time …

Sanofi takes charge of arranged marriage

May 24, 2004

Sanofi-Synthelabo chief executive Jean-Francois Dehecq is preparing his company to merge with larger Franco-German neighbours Aventis to create the world's …

Velcade launched in UK

May 24, 2004

Velcade, the first in a new class of cancer drugs has been launched in the UK as a third line …

UCB snaps up arthritis drug and Celltech in one

May 20, 2004

Brussels-based UCB is to buy the UK's number one biotech company Celltech for around $1.5 billion, creating the world's fifth …

AstraZeneca issues Crestor safety warning

May 20, 2004

AstraZeneca has written to healthcare professionals in the UK after a small number of patients reported serious side effects after …

Addressing the gender divide

May 20, 2004

A recent report by the Equal Opportunity Commission (EOC), Promoting Gender Equality in Health, has highlighted a significant omission which …

GSK establishes strategic link with Theravance

May 20, 2004

GlaxoSmithKline has paid $129 million to a small US biotech company for a three-year worldwide licensing option on all the …

European biotech revenues fall back

May 20, 2004

Revenues from the European biotech sector have fallen back for the first time in 2003, as many companies across the …

Faslodex launched in UK

May 19, 2004
AstraZeneca, Faslodex

The latest addition to AstraZeneca’s oncology franchise, breast cancer drug Faslodex has been launched in the UK.Licensed for the treatment …

Obesity drug collaboration for BMS and Solvay

May 19, 2004

Bristol-Myers Squibb and Solvay are to collaborate on the development and marketing of a novel phase I compound for the …

NICE strikes deal with industry on data confidentiality

May 19, 2004

The industry and NICE have reached  agreement on how the cost and clinical effectiveness body can meet demands for transparency …

TNF-blockers continue to expand indications

May 14, 2004

Competitors in one of the industry's fastest growing markets, the TNF-blocker class of rheumatoid arthritis drugs, have gained extensions to …

New laws to combat animal rights extremists

May 14, 2004

New legislation will be introduced to combat animal rights extremists' violence against those involved in using animals in medical research.But …

GSK sued for ‘abandoning’ Relenza

May 14, 2004

Biota, the Australian biotech company that discovered Relenza, is taking GlaxoSmithKline to court, alleging that it failed to properly launch …

Antisoma and Roche’s ovarian cancer drug disappoints

May 12, 2004

A phase III trial of a drug to treat ovarian cancer has disappointed and is likely to be dropped, co-developers …

The Gateway to Local Adoption Series

Latest content